JP2011137015A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011137015A5 JP2011137015A5 JP2011027692A JP2011027692A JP2011137015A5 JP 2011137015 A5 JP2011137015 A5 JP 2011137015A5 JP 2011027692 A JP2011027692 A JP 2011027692A JP 2011027692 A JP2011027692 A JP 2011027692A JP 2011137015 A5 JP2011137015 A5 JP 2011137015A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- acid
- polyunsaturated fatty
- per
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 16
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 16
- 229940114079 arachidonic acid Drugs 0.000 claims 8
- 235000021342 arachidonic acid Nutrition 0.000 claims 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 8
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 8
- 150000003904 phospholipids Chemical group 0.000 claims 8
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 6
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 4
- 206010051606 Necrotising colitis Diseases 0.000 claims 2
- 208000004995 necrotizing enterocolitis Diseases 0.000 claims 2
- 235000015097 nutrients Nutrition 0.000 claims 2
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000008344 egg yolk phospholipid Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 150000004668 long chain fatty acids Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 239000003182 parenteral nutrition solution Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80470097A | 1997-02-21 | 1997-02-21 | |
| US08/804,700 | 1997-02-21 | ||
| US82531497A | 1997-03-28 | 1997-03-28 | |
| US08/825,314 | 1997-03-28 | ||
| US08/943,576 US6080787A (en) | 1997-02-21 | 1997-10-03 | Methods for reducing the incidence of necrotizing enterocolitis |
| US08/943,576 | 1997-10-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53687198A Division JP2001516343A (ja) | 1997-02-21 | 1998-02-19 | 壊死性全腸炎の発生を減少させるための方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011137015A JP2011137015A (ja) | 2011-07-14 |
| JP2011137015A5 true JP2011137015A5 (cg-RX-API-DMAC7.html) | 2012-04-26 |
Family
ID=27122714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011027692A Pending JP2011137015A (ja) | 1997-02-21 | 2011-02-10 | 壊死性全腸炎の発生を減少させるための方法及び組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6080787A (cg-RX-API-DMAC7.html) |
| JP (1) | JP2011137015A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100439166B1 (cg-RX-API-DMAC7.html) |
| AR (1) | AR011160A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL150490A (cg-RX-API-DMAC7.html) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22723A1 (es) * | 1997-04-02 | 2002-02-28 | Dalmer Lab Sa | Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos |
| EP1090636A1 (en) * | 1999-09-13 | 2001-04-11 | Société des Produits Nestlé S.A. | High lipid diet |
| EP1181870A1 (en) * | 2000-08-22 | 2002-02-27 | Belovo Eggs & Egg Products | Manufactured lipid emulsion having an improved balanced dietary source of vitamin F |
| EP1372641A4 (en) * | 2001-03-05 | 2004-08-25 | Stephen P Ernest | ENTERAL FORMULATION |
| US6620427B2 (en) * | 2001-04-24 | 2003-09-16 | Abbott Laboratories | Method for improving bone mineralization |
| EP1392278A4 (en) * | 2001-05-14 | 2005-05-04 | Martek Biosciences Corp | PREPARATION AND USE OF A POLAR LIPIDREICH FRACTION WITH STEARIDONIC ACID AND GAMMA LINOLIC ACID FROM PLANT SEEDS AND MICROBES |
| EP1392623A4 (en) * | 2001-05-14 | 2005-05-04 | Martek Biosciences Corp | PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS |
| JP2003048831A (ja) * | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| US20040013787A1 (en) * | 2002-06-28 | 2004-01-22 | Theuer Richard C. | Fat compositions for infant formula and methods therefor |
| KR101195574B1 (ko) * | 2002-09-24 | 2012-10-30 | 산토리 홀딩스 가부시키가이샤 | 아라키돈산을 단독으로 또는 도코사헥사엔산과의 조합으로함유하는 인지 능력 향상용 조성물 |
| DK1589834T3 (da) * | 2003-02-05 | 2007-06-18 | Nutricia Nv | Enteral komposition til forebyggelse og/eller behandling af sepsis |
| GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
| KR20060030860A (ko) * | 2003-06-24 | 2006-04-11 | 유니버시티 오브 캔사스 메디컬 센터 | 유아 조제유 |
| EP2324828A1 (en) * | 2003-08-18 | 2011-05-25 | BTG International Limited | Treatment for neurodegenerative conditions |
| JP4522075B2 (ja) * | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP2006083136A (ja) * | 2004-09-17 | 2006-03-30 | Suntory Ltd | ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
| GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
| GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
| CA2645645C (en) * | 2005-05-23 | 2015-07-14 | Massachusetts Institute Of Technology | Compositions containing pufa and methods of use thereof |
| JP5697293B2 (ja) * | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| JP5967855B2 (ja) * | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
| US7829126B2 (en) | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
| US20070166354A1 (en) * | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
| KR101578498B1 (ko) * | 2006-12-28 | 2015-12-18 | 산토리 홀딩스 가부시키가이샤 | 신경 재생제 |
| WO2008147562A2 (en) * | 2007-05-25 | 2008-12-04 | Childrens's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
| CN101801200B (zh) * | 2007-09-17 | 2014-10-29 | 康奈尔大学 | 用于预防或治疗胃肠病症的支链脂肪酸 |
| EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| US20110200645A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Free Fatty Acid Emulsions |
| US20110206741A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | DHA Triglyceride Emulsions |
| WO2011103510A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha ester emulsions |
| EP3338784B1 (en) | 2010-12-31 | 2020-07-22 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
| MX388089B (es) | 2010-12-31 | 2025-03-19 | Abbott Lab | Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas. |
| EP2658400A2 (en) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
| DK2658399T4 (da) | 2010-12-31 | 2024-03-25 | Abbott Lab | Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion |
| NZ611807A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
| BR112013016929A2 (pt) | 2010-12-31 | 2019-09-24 | Abbott Lab | oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas |
| ES2804258T3 (es) | 2010-12-31 | 2021-02-05 | Abbott Lab | Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios |
| DK2734210T3 (en) | 2011-07-22 | 2018-01-22 | Abbott Lab | GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL |
| US10639319B2 (en) | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| WO2014078544A1 (en) * | 2012-11-14 | 2014-05-22 | Abbott Laboratories | Compositions and methods for improving the long term safety of powdered infant formulas |
| MX2015007935A (es) | 2012-12-18 | 2015-10-09 | Abbott Lab | Fortificador de leche humana liquido concentrado que contiene proteina hipoalergenica y luteina. |
| WO2017117121A1 (en) * | 2015-12-28 | 2017-07-06 | Abbott Laboratories | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3374914D1 (en) * | 1982-04-12 | 1988-01-28 | Univ Texas | Methods and compositions for treating gastro-intestinal ulcer diesease |
| US4670285A (en) * | 1982-08-06 | 1987-06-02 | The University Of Toronto Innovations Foundation | Infant formula |
| US4784861A (en) * | 1986-11-24 | 1988-11-15 | Cca Industries, Inc. | Weight-control formulation |
| US4918063A (en) * | 1987-02-17 | 1990-04-17 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
| US5032585A (en) * | 1987-02-17 | 1991-07-16 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy |
| US4950656A (en) * | 1987-02-17 | 1990-08-21 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
| US5043329A (en) * | 1987-02-17 | 1991-08-27 | Board Of Regents, University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
| DE3734147C2 (de) * | 1987-10-09 | 1998-10-29 | Braun Melsungen Ag | Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung |
| US5000975A (en) * | 1988-12-29 | 1991-03-19 | American Home Products Corporation | Randomized palm oil fat composition for infant formulas |
| US5658767A (en) * | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
| WO1992012711A1 (en) * | 1991-01-24 | 1992-08-06 | Martek Corporation | Microbial oil mixtures and uses thereof |
| WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
| FR2721481B1 (fr) * | 1994-06-27 | 1996-09-06 | Inst Rech Biolog Sa | Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel. |
| DK0784437T3 (da) * | 1994-10-05 | 1999-04-19 | Milupa Gmbh & Co Kg | Phospholipidholdig fedtblanding med LCP-fedtsyrer |
| JPH09201A (ja) * | 1995-06-23 | 1997-01-07 | Akikuni Yakida | 炎症性腸疾患用食品 |
| US5917068A (en) * | 1995-12-29 | 1999-06-29 | Eastman Chemical Company | Polyunsaturated fatty acid and fatty acid ester mixtures free of sterols and phosphorus compounds |
| US6200624B1 (en) * | 1996-01-26 | 2001-03-13 | Abbott Laboratories | Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
-
1997
- 1997-10-03 US US08/943,576 patent/US6080787A/en not_active Expired - Lifetime
-
1998
- 1998-02-19 KR KR10-1999-7007598A patent/KR100439166B1/ko not_active Expired - Fee Related
- 1998-02-20 AR ARP980100780A patent/AR011160A1/es unknown
-
2002
- 2002-06-30 IL IL150490A patent/IL150490A/en not_active IP Right Cessation
-
2011
- 2011-02-10 JP JP2011027692A patent/JP2011137015A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019147836A5 (cg-RX-API-DMAC7.html) | ||
| Teoh et al. | Erratum to “Genetically improved farmed Nile tilapia and red hybrid tilapia showed differences in fatty acid metabolism when fed diets with added fish oil or a vegetable oil blend” | |
| Betancor et al. | Influence of dietary docosahexaenoic acid in combination with other long-chain polyunsaturated fatty acids on expression of biosynthesis genes and phospholipid fatty acid compositions in tissues of post-smolt Atlantic salmon (Salmo salar) | |
| Wang et al. | Dietary carbohydrate levels and lipid sources modulate the growth performance, fatty acid profiles and intermediary metabolism of blunt snout bream Megalobrama amblycephala in an interactive pattern | |
| PH12014501828A1 (en) | Methods, compositions, and devices for supplying dietary fatty acid needs | |
| Nguyen et al. | Growth performance and immune status in common carp Cyprinus carpio as affected by plant oil-based diets complemented with β-glucan | |
| PH12013501433A1 (en) | High protein nutritional compositions and methods of making and using same | |
| NZ595204A (en) | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof | |
| BR112014001907A2 (pt) | produção de dha e outros lc-pufas em plantas | |
| JP2011255373A5 (cg-RX-API-DMAC7.html) | ||
| RU2017119470A (ru) | Способ лечения нейротравмы | |
| JP2008519796A (ja) | 脂質混合物含有栄養物 | |
| Lemahieu et al. | Effect of different microalgal n− 3 PUFA supplementation doses on yolk color and n− 3 LC-PUFA enrichment in the egg | |
| WO2011137160A3 (en) | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans | |
| CA2905817A1 (en) | Reducing the risk of autoimmune disease | |
| US20070254954A1 (en) | Composition with Preventive or Improvement Effect on Symptoms or Disesases Associted with Stress-Induced Behavior Disorders | |
| SG10201806517QA (en) | Compositions and methods for nutrient delivery | |
| Molnár et al. | Fatty acid profile of fillet, liver and mesenteric fat in tilapia (Oreochromis niloticus) fed vegetable oil supplementation in the finishing period of fattening | |
| US20090191306A1 (en) | Nutritional composition containing dha, rumenic acid, and gangliosides | |
| RU2013124962A (ru) | Композиции и способы доставки питательных веществ | |
| GAO et al. | Research advances on function of docosahexaenoic acid-microalgae oil. | |
| Sanders | Polyunsaturated fatty acid status in vegetarians | |
| PH12013502639B1 (en) | Method for reducing the occurrence of infection in young children | |
| Slomma et al. | The effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acids on Δ4-desaturation in HepG2 cells | |
| Brinkworth | Omega 3: SDA-an omega of emerging importance in cardiometabolic health |